On the occasion of World Kidney Day, Manipal Hospital Millers Road, hosted an awareness session to highlight the growing concerns surrounding kidney disease. As part of the larger campaign emphasizing ...

Dr MKO AbimbolaEnd-stage kidney dis­ease is the last stage (5th stage) of chronic kid­ney disease (CKD). ESRD is also called kidney fail­ure, which develops when the treatment of CKD is either delayed ...

The FDA accepts Apellis' sNDA seeking label expansion of Empaveli to treat two rare kidney diseases for review under the Priority Review pathway.

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed. The consequences of advanced chronic ...

The supplemental New Drug Application for the C3G and IC-MPGN indications is supported by data from the phase 3 VALIANT study.

Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood ...

A suburban man with 100% kidney failure is fighting to help free his brother on humanitarian parole after being detained by ICE.

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.

Among middle-aged women, low creatinine-to-cystatin C ratio (CCR) at baseline is associated with lower fat-free muscle volumes and poorer gait speeds 6.6 years later.